Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
Herbert Smith Freehills Kramer (HSF Kramer) is pleased to be advising CSL on its recently announced proposed demerger of its Seqirus business (Seqirus) as a standalone ASX-listed entity by the end of Financial Year 2026.
Seqirus is one of the world’s largest influenza vaccine providers, dedicated to advancing public health through innovative vaccine solutions and pandemic preparedness.
The HSF Kramer team is led by partners Priscilla Bryans, Baden Furphy, Alexander Mackinnon, and Michael Ziegelaar, with partner Ryan Leslie advising on the tax aspects of the transaction.
Key contacts
Priscilla Bryans
Partner, Melbourne
Baden Furphy
Partner, Melbourne
Alexander Mackinnon
Partner, Melbourne
Michael Ziegelaar
Partner, Melbourne
Ryan Leslie
Partner, Melbourne
Media contact
For further information on this news article, please contact:
Gina Baldassarre
External Communications Manager
Sydney
More news
1 ตุลาคม 2026
Kathryn Sanger to lead ICC-HK’s arbitration leadership team
The International Chamber of Commerce – Hong Kong, China (ICC-HK) has today announced the appointment of Kathryn Sanger, an international arbitration …
1 ตุลาคม 2026
Herbert Smith Freehills Kramer advises The Living Company on Melbourne’s State Library Exchange development
HSF Kramer has advised The Living Company on the fund through arrangements for the State Library Exchange development in Melbourne and on its partnership …
1 ตุลาคม 2026
Herbert Smith Freehills Kramer hires life sciences regulatory partner Marie Manley in London
Leading global law firm Herbert Smith Freehills Kramer (HSF Kramer) has hired Marie Manley, as a partner and Head of Life Sciences Regulatory, in London.